Pay in 4 interest-free payments of $5.40 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
When you use an insulin syringe to draw semaglutide, the "unit" markings are simply measuring volume in hundredths of a milliliter
Explore how this biopharma is advancing neuropsychiatry care at by Soumya Shashikumar
The study was conducted with 41 male rats that received contusion injuries or sham procedures
First, System Xc (cystine/glutamate antiporter) is constructed from the heavy chain SLC3A2 and light chain SLC7A11 (xCT) (Tu et al., 2021)
